Oragenics (OGEN) Catches Eye: Stock Rises 9.7% - Tale of the Tape
May 14 2014 - 9:46AM
Zacks
Oragenics Inc. (OGEN) was a big
mover last session with its shares rising nearly 10% on the day.
The move came on solid volume too with far more shares changing
hands than in a normal session. This reverses the recent downtrend
of the company as the stock has lost nearly 25% in the past
one-month time frame.
This biotechnology company has seen no estimate revision in the
last 30 days. The Zacks Consensus Estimate hasn’t been in a trend
either. Yesterday’s price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Oragenics currently has a Zacks Rank #3 (Hold) while its Earnings
ESP is 0.00%.
Investors interested in the biomedical industry may consider stocks
like Myriad Genetics Inc. (MYGN), Gilead
Sciences Inc. (GILD) and Illumina Inc.
(ILMN). All three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days. Click
to get this free report
GILEAD SCIENCES (GILD): Free Stock Analysis Report
ILLUMINA INC (ILMN): Free Stock Analysis Report
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
ORAGENICS INC (OGEN): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Apr 2023 to Apr 2024